Unaudited AMPYRAA 2013 Fourth Quarter Net Sales of $84 Million and Unaudited 2013 Full-Year Net Sales of $302 Million ARDSLEY, N.Y.-- --Acorda Therapeutics, Inc. today announced that AMPYRAA Extended Release Tablets, 10 mg unaudited net sales for the fourth quarter of 2013 were $84 million, and unaudited AMPYRA 2013 full-year net sales were $302 ... (more)
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20140113005576&newsLang=en&ndmConfigId=1000639&vnsId=41
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20140113005576&newsLang=en&ndmConfigId=1000639&vnsId=41
No comments:
Post a Comment